Eli Lilly (NYSE: LLY), a juggernaut on the stock exchange with a $700 billion-plus market capitalization, has a lot going for it these days that should encourage investors. After all, its products are at the forefront of treating diabetes and weight loss.But one thing investors shouldn't expect are huge share buybacks by the company. After all, the pharmaceutical sector requires heavy capital.
Open FlipStock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation.
Open FlipOccasionally, clients send us details of portfolio management services (PMS) product offerings for our feedback. Our general view is that all PMS offerings are guilty unless proved innocent. This is because it’s difficult to decipher their investment strategy and compare their performance against the right benchmark.
Open Flip